When attached to supporting electronics, the sensor can wirelessly transmit data to the user’s cell phone through Bluetooth.
One feature of the COVID-19 virus that makes it so difficult to contain is that it can be easily spread to others by a person who has yet to show any signs of infection. The carrier of the virus might feel perfectly well and go about their daily business–taking the virus with them to work, to the home of a family member, or to public gatherings.
A crucial part of the global effort to stem the spread of the pandemic, therefore, is the development of tests that can rapidly identify infections in people who are not yet symptomatic.
Now, Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.
The research was conducted in the lab of Wei Gao, assistant professor in the Andrew and Peggy Cherng department of medical engineering.. Previously, Gao and his team have developed wireless sensors that can monitor conditions such as gout, as well as stress levels, through the detection of extremely low levels of specific compounds in blood, saliva, or sweat.
Gao’s sensors are made of graphene, a sheet-like form of carbon. A plastic sheet etched with a laser generates a 3D graphene structure with tiny pores. Those pores create a large amount of surface area on the sensor, which makes it sensitive enough to detect, with high accuracy, compounds that are only present in very small amounts. In this sensor, the graphene structures are coupled with antibodies, immune system molecules that are sensitive to specific proteins, like those on the surface of a COVID virus, for example.
Previous versions of the sensor were impregnated with antibodies for the hormone cortisol, which is associated with stress, and uric acid, which at high concentrations causes gout. The new version of the sensor, which Gao has named SARS-CoV-2 RapidPlex, contains antibodies and proteins that allow it to detect the presence of the virus itself; antibodies created by the body to fight the virus; and chemical markers of inflammation, which indicate the severity of the COVID-19 infection.
“This is the only telemedicine platform I’ve seen that can give information about the infection in three types of data with a single sensor,” Gao says. “In as little as a few minutes, we can simultaneously check these levels, so we get a full picture about the infection, including early infection, immunity, and severity.”
Established COVID-testing technologies usually take hours or even days to produce results. Those technologies also require expensive, complicated equipment, whereas Gao’s system is simple and compact.
So far, the device has been tested only in the lab with a small number of blood and saliva samples obtained for medical research purposes from individuals who have tested positive or negative for COVID-19. Though preliminary results indicate that the sensor is highly accurate, a larger-scale test with real-world patients rather than laboratory samples must be performed, Gao cautions, to definitively determine its accuracy.
With the pilot study now completed, Gao next plans to test how long the sensors last with regular use, and to begin testing them with hospitalized COVID-19 patients. Following in-hospital testing, he would like to study the suitability of the tests for in-home use. Following testing, the device will need to receive regulatory approval before it is available for widespread use at home.
“Our ultimate aim really is home use,” he says. “In the following year, we plan to mail them to high-risk individuals for at-home testing. And in the future, this platform could be modified for other types of infectious disease testing at home.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- WATCH NOW: Weekend Preview: COVID-19, Smoke Detectors, Leaders of Tomorrowon April 16, 2021 at 5:30 pm
News Editor Hannah Schrodt and News Reporter Molly Hunter break down the biggest stories this weekend, from COVID-19 to Leaders of Tomorrow.
- 'Much more secure': Metal detectors, enhanced security likely when Erie City Hall reopenson April 16, 2021 at 8:03 am
A consultant working with Mayor Joe Schember's administration has recommended the city increase security at City Hall, 626 State St.
- A sensor injected under the skin, backed by DARPA, is meant to spot COVID-19 days before symptoms appearon April 16, 2021 at 5:06 am
A tiny strip of gel is injected under the skin and senses a change in the body's chemistry that can tell a sensor that an infection is developing.
- Global Wireless Fire Detector Market Size, Share, Value, and Competitive Landscape 2024on April 16, 2021 at 4:16 am
Global Wireless Fire Detector Market Overview: Global Wireless Fire Detector Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The ...
- X-Ray Detectors Market 2021 Global Technology, Development, Industry Share, Size, Growth, Trends and COVID-19 Impact Analysis 2027on April 16, 2021 at 4:16 am
The Global X-Ray Detectors Market is expected to exceed more than US$ 3.0 Billion by 2024 at a CAGR of 5.5% in the ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Rapid detection of COVID-19
- Qorvo Biotechnologies granted emergency use authorization, awarded $24.4M contract, to produce COVID-19 rapid teston April 16, 2021 at 12:15 pm
A new rapid antigen test that can identify whether a patient is COVID-19 positive in 20 minutes developed by Qorvo Biotechnologies has received emergency use authorization from the FDA, and the NIH aw ...
- Detection of Coronavirus P.1 Variant Confirmed in Yolo Countyon April 15, 2021 at 3:03 pm
As part of its free COVID-19 testing operations, Healthy Davis Together and the UC Davis Genome Center identified the first-known case of the P.1 variant of SARS-CoV-2, the virus that causes COVID-19, ...
- Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 ...on April 15, 2021 at 1:01 pm
Qorvo® (Nasdaq: QRVO), a leading provider of innovative radio frequency (RF) solutions that connect the world, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency ...
- LifeLabs partners with Fionet Rapid Response Group to implement COVID-19 rapid diagnostic testing serviceson April 15, 2021 at 7:16 am
LifeLabs, Canada's largest provider of laboratory services, is pleased to sign an exclusive agreement with Fionet ...
- Novel application of automated machine learning with MALDI-TOF-MS for rapid high-throughput screening of COVID-19: a proof of concepton April 15, 2021 at 3:40 am
The 2019 novel coronavirus infectious disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a significant demand for testing 1, 2. In the ...